Indication

Acute maxillary Moraxella catarrhalis sinusitis

Acute maxillary *Moraxella catarrhalis* sinusitis is an acute bacterial infection of the upper respiratory tract specifically involving the mucosal lining of one or both maxillary paranasal sinuses. Read more about Acute maxillary Moraxella catarrhalis sinusitis

184 drugs 88 manufacturers

Advertisement

Drugs that treat it

Common Acute maxillary Moraxella catarrhalis sinusitis therapies.

Showing 154–162 of 184 drugs

CEFDINIR

BETA-LACTAMS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+15
ASCEND LABORATO

CEFDINIR

BETA-LACTAMS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+15
DENTON PHARMA I
Filter & compare in the drug finder →Opens the drug finder with Acute maxillary Moraxella catarrhalis sinusitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Acute maxillary Moraxella catarrhalis sinusitis.

Acute maxillary *Moraxella catarrhalis* sinusitis is an acute bacterial infection of the upper respiratory tract specifically involving the mucosal lining of one or both maxillary paranasal sinuses.

Pathophysiologically, the condition commonly develops following viral rhinitis or ostiomeatal obstruction, which leads to impaired mucociliary clearance and allows contiguous proliferation of the gram-negative diplococcus *Moraxella catarrhalis*.

The condition affects both pediatric and adult populations, presenting clinically with sudden-onset facial pain or pressure localized over the cheek and upper teeth, nasal congestion, purulent nasal discharge, and sometimes fever lasting fewer than four weeks.

Personalize your experience

Follow Acute maxillary Moraxella catarrhalis sinusitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it